DrugPatentWatch Database Preview
Litigation Details for Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc. (N.D. Cal. 2011)
Email this page to a colleague
See Plans and PricingTakeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc. (N.D. Cal. 2011)
| Docket | Start Trial | Date Filed | 2011-04-01 |
| Court | District Court, N.D. California | Date Terminated | 2013-11-01 |
| Cause | 35:271 Patent Infringement | Assigned To | Joseph C. Spero |
| Jury Demand | None | Referred To | Jacqueline Scott Corley |
| Parties | HANDA PHARMACEUTICALS, LLC; IMPAX LABORATORIES, INC.; IMPAX LABORATORIES, INC.,; PAR PHARMACEUTICAL, INC.; SANDOZ INC.; TAKEDA PHARMACEUTICAL CO., LTD.; TAKEDA PHARMACEUTICALS AMERICA, INC.; TAKEDA PHARMACEUTICALS LLC; TAKEDA PHARMACEUTICALS NORTH AMERICA, INC. | ||
| Patents | 4,628,098; 5,045,321; 5,326,570; 5,470,584; 5,817,338; 5,840,737; 5,972,389; 6,162,463; 6,228,398; 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755 | ||
| Attorneys | Brian Francis McMahon; David C. Doyle; Edward George Dane; Eric Martin Acker; Erin Joan Cox; Heather E. Takahashi; Jeffrey I. Weinberger; Jessica E. La Londe; Joel Matthew Purles; Marc Dana Sharp; Mark T. Jansen; Parisa Jorjani; Pilar Stillwater; Ryan Neil Hagglund; Ted G. Dane , Esq.; Tina Wang Arroyo | ||
| Firms | Christensen O'Connor Johnson Kindness PLLC; Crowell and Moring LLP; Morrison & Foerster LLP; Morrison and Foerster; Munger Tolles & Olson LLP; Munger Tolles Olson LLP; Munger, Tolles & Olson LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc. (N.D. Cal. 2011)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2011-04-01 | 1 | agent. U.S. PATENT DOCUMENTS 4,628,098 A 12/1986 Nohara et a1… U.S. PATENT DOCUMENTS Chao 4,628,098 A j 2/1'…example, alkali metal salts such as No. 4,628,098 etc. or analogous methods thereto. sodium salt…picoline, No. 4,628,098 etc. or analogous methods thereto. ethanolamiue…and alkaline earth metal salts No. 4,628,098 etc. or analogous methods thereto. such as calcium | External link to document | |
| 2013-05-28 | 305 | Ther. 824 (2009) TX0097 U.S. Patent No. 4,628,098 TX0101 Dexlansoprazole, Section 3.2… of U.S. Patent No. 6,462,058 (the '''058 patent"); U.S. Patent No. 6,664,276…#39;'276 patent"); U.S. Patent No. 7,285,668 (the "'668 patent"); U.S….S. Patent No. 6,939,971 (the '''971 patent"); U.S. Patent No. 7,737,282 …'282 patent"); U.S. Patent No.7, 790, 755 (the '''755 patent") TX0089x06 | External link to document | |
| 2013-05-30 | 308 | infringe U.S. Patent No. 6,462,058 ("the '058 23 Patent"), U.S. Patent No. 6,… 24 Patent") and U.S. Patent No. 7,790,755 ("the '75 5 Patent") (collectively…6,664,276 ("the '276 Patent"), U.S. Patent No. 6,939,971 ("the '971 …infringed U.S. Patent No. 27 7,285,668 ("the '668 Patent").…based on the '668 Patent, as well as Impax's counterclaims based on that patent, pursuant | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
